Showing results (1-10 of 446) with videos related to
Sort By:
Pageof 45
Chemical Record (New York, N.Y.)|October 3, 2018
Drug Design Concepts for LSD1-Selective InhibitorsYosuke Ota, Takayoshi SuzukiBioorganic & Medicinal Chemistry Letters|December 5, 2017
Histone H3 peptides incorporating modified lysine residues as lysine-specific demethylase 1 inhibitorsTaeko Kakizawa, Yosuke Ota, Yukihiro Itoh, et al.Molecules (Basel, Switzerland)|May 9, 2018
Design, Synthesis, and In Vitro Evaluation of Novel Histone H3 Peptide-Based LSD1 Inactivators Incorporating α,α-Disubstituted Amino Acids with γ-Turn-Inducing StructuresYosuke Ota, Taeko Kakizawa, Yukihiro Itoh, et al.Computational and Structural Biotechnology Journal|April 24, 2014
Synthesis, LSD1 Inhibitory Activity, and LSD1 Binding Model of Optically Pure Lysine-PCPA ConjugatesYukihiro Itoh, Daisuke Ogasawara, Yosuke Ota, et al.Bioorganic & Medicinal Chemistry Letters|April 2, 2015
Histone H3 peptide based LSD1-selective inhibitorsTaeko Kakizawa, Yosuke Ota, Yukihiro Itoh, et al.Chemical & Pharmaceutical Bulletin|October 30, 2018
Design, Synthesis, and Biological Evaluation of a Conjugate of 5-Fluorouracil and an LSD1 InhibitorYosuke Ota, Arisa Nakamura, Elghareeb E Elboray, et al.Chemical & Pharmaceutical Bulletin|August 2, 2016
False HDAC Inhibition by Aurone CompoundYukihiro Itoh, Miki Suzuki, Taiji Matsui, et al.Plos One|July 23, 2013
Identification of highly selective and potent histone deacetylase 3 inhibitors using click chemistry-based combinatorial fragment assemblyTakayoshi Suzuki, Yuki Kasuya, Yukihiro Itoh, et al.Angewandte Chemie (International Ed. in English)|November 25, 2016
Targeting Cancer with PCPA-Drug Conjugates: LSD1 Inhibition-Triggered Release of 4-HydroxytamoxifenYosuke Ota, Yukihiro Itoh, Asako Kaise, et al.Bioorganic & Medicinal Chemistry Letters|March 29, 2014
Identification of novel SIRT2-selective inhibitors using a click chemistry approachPrima R Tatum, Hideyuki Sawada, Yosuke Ota, et al.Pageof 45